CD8A and neoplasm: Combination therapy led to changes in the tumor microenvironment including increases in CD8 T cell infiltration as well as significantly increased CD8/Treg, CD4 Teff/Treg, and CD8/MDSC ratios, which favor tumor clearance and successful treatment.